David Ricks 称美国仅有 3% 至 10% 的潜在患者接受减重治疗,市场扩张空间巨大。
礼来负责人 David Ricks 在接受 CNBC 采访时表示,美国只有 3% 至 10% 的潜在患者获得减重治疗,并补充说“这个市场的扩张空间非常巨大”。原文 (en)
Lilly chief David Ricks, in a CNBC interview, said that only 3% to 10% of potential patients access weight loss care in the U.S., and he added that "room for expansion here of this market is dramatic."